Lexaria Bioscience (LEXX) Q2 2026 Earnings

13AprConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.21
-0.16
-0.12
-0.07

Details

Expected EPS
-0.07
Actual EPS
-0.07
Surprise EPS
0
Surprise Percent
+0%

Description

Lexaria Bioscience (LEXX) has reported earnings of -0.07 per share for Q2 2026.

0 Comments

Share your thoughts